Do you want to visit the AmgenPro website and leave Amgen.nl?
You are now leaving the Amgen Netherlands website and will be redirected to AmgenPro – the portal designed specifically for healthcare professionals. This website is only available in Dutch. Healthcare professionals who are authorized to prescribe medication, can create an account using their BIG number and will then gain access to all available information.
By selecting the Yes option, leaving Amgen.nl option you understand that you are leaving the corporate page of Amgen nl and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen nl is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in nl. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
By selecting the Yes option, leaving Amgen.nl option you understand that you are leaving the corporate page of Amgen nl and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen nl is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in nl. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
When people are affected by diseases, they deserve the best possible treatment. Thanks to the development of innovative medicines, it is possible to achieve increasingly better treatment outcomes for them. With the discovery, development and delivery of biologics, we serve patients in the fields of oncology, hematology, cardiovascular disease, bone diseases and inflammatory (rare) diseases.
Read more about which biologics and biosimilars we sell in the Netherlands and how they tackle diseases.